[1] Alexander DB, Goldberg GS. Transfer of biologically important molecules between cells through gap junction channels.  Curr Med Chem 2003; 10: 2045-2058.

[2] Decrock E, Vinken M, De Vuyst E, Krysko DV, D'Herde K,  Vanhaecke T, et al. Connexin-related signaling in cell death: to  live or let die? Cell Death Differ 2009; 16: 524-536.

[3] Meens MJ, Kwak BR, Duffy HS. Role of connexins and  pannexins in cardiovascular physiology. Cell Mol Life Sci  2015; 72: 2779-2792.

[4] Losa D, Chanson M. The lung communication network. Cell  Mol Life Sci 2015; 72: 2793-2808.

[5] Maes M, Cogliati B, Crespo Yanguas S, Willebrords J, Vinken  M. Roles of connexins and pannexins in digestive homeostasis.  Cell Mol Life Sci 2015; 72: 2809-2821.

[6] Decrock E, De Bock M, Wang N, Bultynck G, Giaume C,  Naus CC, et al. Connexin and pannexin signaling pathways, an  architectural blueprint for CNS physiology and pathology?  Cell Mol Life Sci 2015; 72: 2823-2851.

[7] Plotkin LI, Stains JP. Connexins and pannexins in the skeleton:  gap junctions, hemichannels and more. Cell Mol Life Sci  2015;72:2853-2867.

[8] Abed AB, Kavvadas P, Chadjichristos CE. Functional roles of  connexins and pannexins in the kidney. Cell Mol Life Sci  2015;72:2869-2877.

[9] Kibschull M, Gellhaus A, Carette D, Segretain D, Pointis G,  Gilleron J. Physiological roles of connexins and pannexins in  reproductive organs. Cell Mol Life Sci 2015; 72: 2879-2898.

[10] Glass AM, Snyder EG, Taffet SM. Connexins and pannexins  in the immune system and lymphatic organs. Cell Mol Life Sci  2015; 72: 2899-2910.

[11] Hodson DJ, Legros C, Desarménien MG, Guérineau NC.  Roles of connexins and pannexins in (neuro)endocrine physiology. Cell Mol Life Sci 2015; 72: 2911-2928.

[12] Sáez JC, Cisterna BA, Vargas A, Cardozo CP. Regulation of  pannexin and connexin channels and their functional role in  skeletal muscles. Cell Mol Life Sci 2015; 72: 2929-2935.

[13] Faniku C, Wright CS, Martin PE. Connexins and pannexins inthe integumentary system: the skin and appendages. Cell Mol  Life Sci 2015; 72: 2937-2947.

[14] Loewenstein WR, Kanno Y. Intercellular communication and  tissue growth. I. Cancerous growth. J Cell Biol 1967; 33: 225- 234.

[15] Revel JP, Karnovsky MJ. Hexagonal array of subunits in  intercellular junctions of the mouse heart and liver. J Cell Biol  1967; 33: C7-C12.

[16] Goodenough DA. Bulk isolation of mouse hepatocyte gap  junctions. Characterization of the principal protein, connexin.  J Cell Biol 1974; 61: 557-563.

[17] Söhl G, Willecke K. An update on connexin genes and their  nomenclature in mouse and man. Cell Commun Adhes 2003; 10: 173-180.

[18] Dahl G, Werner R, Levine E, Rabadan-Diehl C. Mutational  analysis of gap junction formation. Biophys J 1992; 62: 172- 180; 180-172.

[19] Unger VM, Kumar NM, Gilula NB, Yeager M. Three-dimensional structure of a recombinant gap junction membrane  channel. Science 1999; 283: 1176-1180.

[20] Yeager M, Nicholson BJ. Structure of gap junction intercellular channels. Curr Opin Struct Biol 1996; 6: 183-192.

[21] Foote CI, Zhou L, Zhu X, Nicholson BJ. The pattern of  disulfide linkages in the extracellular loop regions of connexin  32 suggests a model for the docking interface of gap junctions.  J Cell Biol 1998; 140: 1187-1197

[22] Contreras JE, Sanchez HA, Eugenin EA, Speidel D, Theis M,  Willecke K, et al. Metabolic inhibition induces opening of  unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in  culture. Proc Natl Acad Sci U S A 2002; 99: 495-500.

[23] Chandrasekhar A, Bera AK. Hemichannels: permeants and  their effect on development, physiology and death. Cell  Biochem Funct 2012; 30: 89-100.

[24] Spray DC, Ye ZC, Ransom BR. Functional connexin  "hemichannels": a critical appraisal. Glia 2006; 54: 758-773.

[25] Harris AL. Connexin channel permeability to cytoplasmic  molecules. Prog Biophys Mol Biol 2007; 94: 120-143.

[26] Wang N, De Bock M, Decrock E, Bol M, Gadicherla A,  Vinken M, et al. Paracrine signaling through plasma membrane hemichannels. Biochim Biophys Acta 2013; 1828: 35- 50.

[27] Evans WH, De Vuyst E, Leybaert L. The gap junction cellular  internet: connexin hemichannels enter the signalling limelight.  Biochem J 2006; 397: 1-14.

[28] Vinken M, Doktorova T, Decrock E, Leybaert L, Vanhaecke T,  Rogiers V. Gap junctional intercellular communication as a  target for liver toxicity and carcinogenicity. Crit Rev Biochem  Mol Biol 2009; 44: 201-222.

[29] Vinken M. Gap junctions and non-neoplastic liver disease. J  Hepatol 2012; 57: 655-662.

[30] Cascio M, Kumar NM, Safarik R, Gilula NB. Physical  characterization of gap junction membrane connexons (hemichannels) isolated from rat liver. J Biol Chem 1995; 270: 18643-18648.

[31] Neveu MJ, Hully JR, Babcock KL, Vaughan J, Hertzberg EL,Nicholson BJ, et al. Proliferation-associated differences in the  spatial and temporal expression of gap junction genes in rat  liver. Hepatology 1995; 22: 202-212.

[32] Fischer R, Reinehr R, Lu TP, Schonicke A, Warskulat U,  Dienes HP, et al. Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology  2005; 128: 433-448.

[33] Eugenin EA, Gonzalez HE, Sanchez HA, Branes MC, Saez JC.  Inflammatory conditions induce gap junctional communication  between rat Kupffer cells both in vivo and in vitro. Cell  Immunol 2007; 247: 103-110.

[34] Gonzalez HE, Eugenin EA, Garces G, Solis N, Pizarro M,  Accatino L, et al. Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory  mediators. Am J Physiol Gastrointest Liver Physiol 2002; 282: G991-G1001.

[35] Berthoud VM, Iwanij V, Garcia AM, Sáez JC. Connexins and  glucagon receptors during development of rat hepatic acinus.  Am J Physiol 1992; 263: 650-658.

[36] Bode HP, Wang L, Cassio D, Leite MF, St-Pierre MV, Hirata K,  et al. Expression and regulation of gap junctions in rat  cholangiocytes. Hepatology 2002; 36: 631-640.

[37] Greenwel P, Rubin J, Schwartz M, Hertzberg EL, Rojkind M.  Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat  are heterogeneous with regard to proliferation, expression of  extracellular matrix components, interleukin-6, and connexin  43. Lab Invest 1993; 69: 210-216

[38] Hernández-Guerra M, González-Méndez Y, de Ganzo ZA,  Salido E, García-Pagán JC, Abrante B, et al. Role of gap  junctions modulating hepatic vascular tone in cirrhosis. Liver  Int 2014; 34: 859-868.

[39] Shiojiri N, Niwa T, Sugiyama Y, Koike T. Preferential  expression of connexin37 and connexin40 in the endothelium  of the portal veins during mouse liver development. Cell  Tissue Res 2006; 324: 547-552.

[40] Chaytor AT, Martin PE, Edwards DH, Griffith TM. Gap  junctional communication underpins EDHF-type relaxations  evoked by ACh in the rat hepatic artery. Am J Physiol Heart  Circ Physiol 2001;2 80: 2441-2450.

[41] Iwai M, Harada Y, Muramatsu A, Tanaka S, Mori T, Okanoue  T, et al. Development of gap junctional channels and  intercellular communication in rat liver during ontogenesis. J  Hepatol 2000; 32: 11-18.

[42] Traub O, Look J, Dermietzel R, Brümmer F, Hülser D,  Willecke K. Comparative characterization of the 21-kD and  26-kD gap junction proteins in murine liver and cultured  hepatocytes. J Cell Biol 1989; 108: 1039-1051.

[43] Zhang JT, Nicholson BJ. The topological structure of connexin  26 and its distribution compared to connexin 32 in hepatic gap  junctions. J Membr Biol 1994; 139: 15-29.

[44] Oyamada M, Oyamada Y, Takamatsu T. Regulation of  connexin expression. Biochim Biophys Acta 2005; 1719: 6-23.

[45] Sáez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV.  Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 2005; 1711: 215-224.

[46] Oyamada M, Takebe K, Oyamada Y. Regulation of connexinexpression by transcription factors and epigenetic mechanisms.  Biochim Biophys Acta 2013; 1828: 118-133.

[47] Piechocki MP, Toti RM, Fernstrom MJ, Burk RD, Ruch RJ.  Liver cell-specific transcriptional regulation of connexin32.  Biochim Biophys Acta 2000; 1491: 107-122. [48] Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch  RJ. Positive regulation of connexin32 transcription by  hepatocyte nuclear factor-1alpha. Arch Biochem Biophys 2002; 407: 160-167.

[49] Field JM, Tate LA, Chipman JK, Minchin SD. Identification  of functional regulatory regions of the connexin32 gene  promoter. Biochim Biophys Acta 2003; 1628: 22-29.

[50] Vinken M. Regulation of connexin signaling by the epigenetic  machinery. Biochim Biophys Acta 2016; 1859: 262-268.

[51] Piechocki MP, Burk RD, Ruch RJ. Regulation of connexin32  and connexin43 gene expression by DNA methylation in rat  liver cells. Carcinogenesis 1999; 20: 401-406.

[52] Vinken M, Henkens T, Vanhaecke T, Papeleu P, Geerts A, Van  Rossen E, et al. Trichostatin a enhances gap junctional  intercellular communication in primary cultures of adult rat  hepatocytes. Toxicol Sci 2006; 91: 484-492.

[53] Vinken M, Henkens T, Snykers S, Lukaszuk A, Tourwé D,  Rogiers V, et al. The novel histone deacetylase inhibitor  4-Me2N-BAVAH differentially affects cell junctions between  primary hepatocytes. Toxicology 2007; 236: 92-102.

[54] Bukauskas FF, Verselis VK. Gap junction channel gating.  Biochim Biophys Acta 2004; 1662: 42-60.

[55] Lampe PD, Lau AF. The effects of connexin phosphorylation  on gap junctional communication. Int J Biochem Cell Biol  2004; 36: 1171-1186.

[56] Peracchia C. Chemical gating of gap junction channels; roles  of calcium, pH and calmodulin. Biochim Biophys Acta 2004; 1662: 61-80.

[57] Cottrell GT, Burt JM. Functional consequences of heterogeneous gap junction channel formation and its influence in  health and disease. Biochim Biophys Acta 2005; 1711: 126- 141.

[58] Pogoda K, Kameritsch P, Retamal MA, Vega JL. Regulation of  gap junction channels and hemichannels by phosphorylation and redox changes: a revision. BMC Cell Biol 2016;17 Suppl  1:11.

[59] Johnstone SR, Billaud M, Lohman AW, Taddeo EP, Isakson  BE. Posttranslational modifications in connexins and pannexins.  J Membr Biol 2012; 245: 319-332.

[60] Retamal MA, Cortés CJ, Reuss L, Bennett MV, Sáez JC.  S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal  by reducing agents. Proc Natl Acad Sci U S A 2006; 103: 4475-4480.

[61] Retamal MA, Froger N, Palacios-Prado N, Ezan P, Saez PJ,  Saez JC, et al. Cx43 hemichannels and gap junction channels  in astrocytes are regulated oppositely by proinflammatory  cytokines released from activated microglia. J Neurosci 2007; 27: 13781-13792.

[62] Kjenseth A, Fykerud TA, Sirnes S, Bruun J, Yohannes Z,  Kolberg M, et al. The gap junction channel protein connexin  43 is covalently modified and regulated by SUMOylation. JBiol Chem 2012; 287: 15851-15861.

[63] Laird DW. Connexin phosphorylation as a regulatory event  linked to gap junction internalization and degradation.  Biochim Biophys Acta 2005; 1711: 172-182.

[64] Cooper CD, Solan JL, Dolejsi MK, Lampe PD. Analysis of  connexin phosphorylation sites. Methods 2000; 20: 196-204.

[65] Solan JL, Lampe PD. Connexin43 phosphorylation: structural  changes and biological effects. Biochem J 2009; 419: 261-272.

[66] Solan JL, Lampe PD. Connexin phosphorylation as a  regulatory event linked to gap junction channel assembly.  Biochim Biophys Acta 2005; 1711: 154-163.

[67] Vinken M, Decrock E, Vanhaecke T, Leybaert L, Rogiers V.  Connexin43 signaling contributes to spontaneous apoptosis in  cultures of primary hepatocytes. Toxicol Sci 2012; 125: 175- 186.

[68] Yang J, Ichikawa A, Tsuchiya T. A novel function of connexin  32: marked enhancement of liver function in a hepatoma cell  line. Biochem Biophys Res Commun 2003; 307: 80-85.

[69] Stumpel F, Ott T, Willecke K, Jungermann K. Connexin 32  gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver. Hepatology 1998; 28: 1616-1620.

[70] Clair C, Chalumeau C, Tordjmann T, Poggioli J, Erneux C,  Dupont G, et al. Investigation of the roles of Ca(2+) and InsP(3) diffusion in the coordination of Ca(2+) signals between connected hepatocytes. J Cell Sci 2001; 114: 1999-2007.

[71] Nelles E, Butzler C, Jung D, Temme A, Gabriel HD, Dahl U,  et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient  mice. Proc Natl Acad Sci U S A 1996; 93: 9565-9570.

[72] Temme A, Stumpel F, Sohl G, Rieber EP, Jungermann K,  Willecke K, et al. Dilated bile canaliculi and attenuated  decrease of nerve-dependent bile secretion in connexin32- deficient mouse liver. Pflugers Archiv 2001; 442: 961-966

[73] Nathanson MH, Rios-Velez L, Burgstahler AD, Mennone A.  Communication via gap junctions modulates bile secretion in  the isolated perfused rat liver. Gastroenterology 1999; 116: 1176-1183.

[74] Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson  BJ, Pitot HC. Colocalized alterations in connexin32 and  cytochrome P450IIB1/2 by phenobarbital and related liver  tumor promoters. Cancer Res 1994; 54: 3145-3152.

[75] Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C,  Imazawa T, et al. The relationship between decrease in Cx32  and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat. Arch Toxicol 1999; 73: 373-380.

[76] Shoda T, Mitsumori K, Onodera H, Toyoda K, Uneyama C,  Takada K, et al. Liver tumor-promoting effect of beta- naphthoflavone, a strong CYP 1A1/2 inducer, and the relationship  between CYP 1A1/2 induction and Cx32 decrease in its hepatocarcinogenesis in the rat. Toxicol Pathol 2000; 28: 540-547.

[77] Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S,  LeCluyse EL. Regulation of cell morphology and cytochrome  P450 expression in human hepatocytes by extracellular matrix  and cell-cell interactions. Cell Tissue Res 2001; 306: 85-99.

[78] Gaspers LD, Thomas AP. Calcium signaling in liver. CellCalcium 2005; 38: 329-342.

[79] Dermietzel R, Yancey SB, Traub O, Willecke K, Revel JP.  Major loss of the 28-kD protein of gap junction in proliferating hepatocytes. J Cell Biol 1987; 105: 1925-1934.

[80] Fladmark KE, Gjertsen BT, Molven A, Mellgren G, Vintermyr  OK, Døskeland SO. Gap junctions and growth control in liver  regeneration and in isolated rat hepatocytes. Hepatology 1997; 25: 847-855.

[81] Koenig S, Krause P, Drabent B, Schaeffner I, Christ B,  Schwartz P, et al. The expression of mesenchymal, neural and  haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol 2006; 44: 1115-1124.

[82] Kojima T, Yamamoto T, Murata M, Lan M, Takano K, Go M,  et al. Role of the p38 MAP-kinase signaling pathway for Cx32  and claudin-1 in the rat liver. Cell Commun Adhes 2003; 10: 437-443.

[83] Kren BT, Kumar NM, Wang SQ, Gilula NB, Steer CJ.  Differential regulation of multiple gap junction transcripts and  proteins during rat liver regeneration. J Cell Biol 1993; 123: 707-718.

[84] Meyer DJ, Yancey SB, Revel JP. Intercellular communication  in normal and regenerating rat liver: a quantitative analysis. J  Cell Biol 1981; 91: 505-523.

[85] Miyashita T, Takeda A, Iwai M, Shimazu T. Single administration of hepatotoxic chemicals transiently decreases the  gap-junction-protein levels of connexin 32 in rat liver. Eur J  Biochem 1991; 196: 37-42.

[86] Sugiyama Y, Ohta H. Changes in density and distribution of  gap junctions after partial hepatectomy: immunohistochemical  and morphometric studies. Arch Histol Cytol 1990; 53: 71-80.

[87] Temme A, Ott T, Dombrowski F, Willecke K. The extent of  synchronous initiation and termination of DNA synthesis in  regenerating mouse liver is dependent on connexin32 expressing gap junctions. J Hepatol 2000; 32: 627-635.

[88] Traub O, Drüge PM, Willecke K. Degradation and resynthesis  of gap junction protein in plasma membranes of regenerating  liver after partial hepatectomy or cholestasis. Proc Natl Acad  Sci U S A 1983; 80: 755-759.

[89] Yee AG, Revel JP. Loss and reappearance of gap junctions in  regenerating liver. J Cell Biol 1978; 78: 554-564.

[90] Dagli ML, Yamasaki H, Krutovskikh V, Omori Y. Delayed  liver regeneration and increased susceptibility to chemical  hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis 2004; 25: 483-492.

[91] Paul DL. Molecular cloning of cDNA for rat liver gap junction  protein. J Cell Biol 1986; 103: 123-134.

[92] Vinken M, Decrock E, De Vuyst E, De Bock M, Vandenbroucke RE, De Geest BG, et al. Connexin32 hemichannels  contribute to the apoptotic-to-necrotic transition during Fasmediated hepatocyte cell death. Cell Mol Life Sci 2010; 67: 907-918.

[93] Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato  S, et al. Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin  43 protein induction in rat. Toxicol Pathol 2010; 38: 280-286.

[94] Saito C, Shinzawa K, Tsujimoto Y. Synchronized necroticdeath of attached hepatocytes mediated via gap junctions. Sci  Rep 2014; 4: 5169.

[95] Zou H, Zhuo L, Han T, Hu D, Yang X, Wang Y, et al. Autophagy and gap junctional intercellular communication inhibition are involved in cadmium-induced apoptosis in rat liver  cells. Biochem Biophys Res Commun 2015; 459: 713-719.

[96] Kalvelyte A, Imbrasaite A, Bukauskiene A, Verselis VK, Bukauskas FF. Connexins and apoptotic transformation. Biochem  Pharmacol 2003; 66: 1661-1672.

[97] Ichai P, Samuel D. Epidemiology of liver failure. Clin Res  Hepatol Gastroenterol 2011; 35: 610-617.

[98] Lee WM. Etiologies of acute liver failure. Semin Liver Dis  2008; 28: 142-152.

[99] Maes M, McGill MR, da Silva TC, Abels C, Lebofsky M, de  Araujo CMM, et al. Involvement of connexin43 in acetaminophen-induced liver injury. Biochim Biophys Acta 2016; 1862: 1111-1121.

[100] Igarashi I, Maejima T, Kai K, Arakawa S, Teranishi M, Sanbuissho A. Role of connexin 32 in acetaminophen toxicity in a  knockout mice model. Exp Toxicol Pathol 2014; 66: 103-110.

[101] Maes M, McGill MR, da Silva TC, Lebofsky M, de Araujo  CMM, Tiburcio T, et al. Connexin32: a mediator of acetaminophen-induced liver injury? Toxicol Mech Methods 2016; 26: 88-96

[102] Park WJ, Park JW, Erez-Roman R, Kogot-Levin A, Bame JR,  Tirosh B, et al. Protection of a ceramide synthase 2 null mouse  from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization. J Biol Chem 2013; 288: 30904-30916.

[103] Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984; 81: 1327-1331.

[104] Maes M, Vinken M, Jaeschke H. Experimental models of  hepatotoxicity related to acute liver failure. Toxicol Appl  Pharmacol 2016; 290: 86-97.

[105] Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, Li M,  et al. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol 2012; 30: 179-183.

[106] Du K, Williams CD, McGill MR, Xie Y, Farhood A, Vinken M,  et al. The gap junction inhibitor 2-aminoethoxy-diphenylborate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase  activation. Toxicol Appl Pharmacol 2013; 273: 484-491.

[107] Fidaleo M. Human health risk assessment for peroxisome  proliferators: more than 30 years of research. Exp Toxicol  Pathol 2009; 61: 215-221.

[108] Roberts RA, Chevalier S, Hasmall SC, James NH, Cosulich  SC, Macdonald N. PPAR alpha and the regulation of cell  division and apoptosis. Toxicology 2002; 181: 167-170.

[109] Gonzalez FJ, Shah YM. PPARalpha: mechanism of species  differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 2008; 246:2-8.

[110] Elcock FJ, Chipman JK, Roberts RA. The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis. Arch  Toxicol 1998; 72: 439-444.

[111] Elcock FJ, Deag E, Roberts RA, Chipman JK. Nafenopin  causes protein kinase C-mediated serine phosphorylation and  loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization. Toxicol Sci 2000; 56: 86-94.

[112] Kamendulis LM, Isenberg JS, Smith JH, Pugh G, Lington AW,  Klaunig JE. Comparative effects of phthalate monoesters on  gap junctional intercellular communication and peroxisome  proliferation in rodent and primate hepatocytes. J Toxicol  Environ Health A 2002; 65: 569-588.

[113] Krutovskikh VA, Mesnil M, Mazzoleni G, Yamasaki H. Inhibition of rat liver gap junction intercellular communication by  tumor-promoting agents in vivo. Association with aberrant  localization of connexin proteins. Lab Invest 1995; 72: 571- 577.

[114] Cowles C, Mally A, Chipman JK. Different mechanisms of  modulation of gap junction communication by non-genotoxic  carcinogens in rat liver in vivo. Toxicology 2007; 238: 49-59.

[115] Tsuda H, Asamoto M, Baba-Toriyama H, Iwahori Y, Hori T,  Kim DJ, et al. Clofibrate-induced neoplastic development in  the rat liver is associated with decreased connexin 32 expression but not with a co-ordinated shift in expression of  marker enzymes. Toxicol Lett 1995; 82-83: 693-699.

[116] Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, et al. Antibodies to tumor necrosis  factor alpha prevent increases in cell replication in liver due to  the potent peroxisome proliferator, WY-14,643. Carcinogenesis 1997; 18: 669-674

[117] Roberts RA, James NH, Cosulich S, Hasmall SC, Orphanides  G. Role of cytokines in non-genotoxic hepatocarcinogenesis:  cause or effect? Toxicol Lett 2001; 120: 301-306.

[118] Chandross KJ, Spray DC, Cohen RI, Kumar NM, Kremer M,  Dermietzel R, et al. TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol Cell Neurosci 1996; 7: 479-500.

[119] van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ.  Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein  endothelial cells. Cytokine 1998; 10: 258-264.

[120] Mensink A, de Haan LH, Lakemond CM, Koelman CA,  Koeman JH. Inhibition of gap junctional intercellular communication between primary human smooth muscle cells by  tumor necrosis factor alpha. Carcinogenesis 1995; 16: 2063- 2067.

[121] Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J,  Willecke K, et al. Lack of phenobarbital-mediated promotion  of hepatocarcinogenesis in connexin32-null mice. Cancer Res  2000; 60: 5087-5091.

[122] Luebeck EG, Buchmann A, Schneider D, Moolgavkar SH,  Schwarz M. Modulation of liver tumorigenesis in Connexin32-deficient mouse. Mutat Res 2005; 570: 33-47.

[123] Stahl S, Ittrich C, Marx-Stoelting P, Köhle C, Ott T, Buchmann A, et al. Effect of the tumor promoter phenobarbital on  the pattern of global gene expression in liver of connexin32- wild-type and connexin32-deficient mice. Int J Cancer 2005; 115: 861-869.

[124] Marx-Stoelting P, Mahr J, Knorpp T, Schreiber S, Templin MF,  Ott T, et al. Tumor promotion in liver of mice with a conditional Cx26 knockout. Toxicol Sci 2008; 103: 260-267.

[125] Neveu MJ, Hully JR, Paul DL, Pitot HC. Reversible alteration  in the expression of the gap junctional protein connexin 32  during tumor promotion in rat liver and its role during cell  proliferation. Cancer Commun 1990; 2: 21-31.

[126] Ito S, Tsuda M, Yoshitake A, Yanai T, Masegi T. Effect of  phenobarbital on hepatic gap junctional intercellular communication in rats. Toxicol Pathol 1998; 26: 253-259.

[127] Jeong SH, Habeebu SS, Klaassen CD. Cadmium decreases gap  junctional intercellular communication in mouse liver. Toxicol  Sci 2000; 57: 156-166.

[128] Warner KA, Fernstrom MJ, Ruch RJ. Inhibition of mouse  hepatocyte gap junctional intercellular communication by  phenobarbital correlates with strain-specific hepatocarcinogenesis. Toxicol Sci 2003; 71: 190-197.

[129] Sugie S, Mori H, Takahashi M. Effect of in vivo exposure to  the liver tumor promoters phenobarbital or DDT on the gap  junctions of rat hepatocytes: a quantitative freeze-fracture  analysis. Carcinogenesis 1987; 8: 45-51.

[130] Okamiya H, Mitsumori K, Onodera H, Ito S, Imazawa T,  Yasuhara K, et al. Mechanistic study on liver tumor promoting  effects of piperonyl butoxide in rats. Arch Toxicol 1998; 72: 744-750

[131] Beer DG, Neveu MJ, Paul DL, Rapp UR, Pitot HC. Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. Cancer  Res 1988; 48: 1610-1617.

[132] Mesnil M, Fitzgerald DJ, Yamasaki H. Phenobarbital specifically reduces gap junction protein mRNA level in rat liver.  Mol Carcinog 1988; 1: 79-81.

[133] Klaunig JE, Ruch RJ. Strain and species effects on the  inhibition of hepatocyte intercellular communication by liver  tumor promoters. Cancer Lett 1987; 36: 161-168.

[134] Ren P, Mehta PP, Ruch RJ. Inhibition of gap junctional  intercellular communication by tumor promoters in connexin43 and connexin32-expressing liver cells: cell specificity and  role of protein kinase C. Carcinogenesis 1998; 19: 169-175.

[135] Klaunig JE, Ruch RJ, Weghorst CM. Comparative effects of  phenobarbital, DDT, and lindane on mouse hepatocyte gap  junctional intercellular communication. Toxicol Appl Pharmacol 1990; 102: 553-563.

[136] Auman JT, Chou J, Gerrish K, Huang Q, Jayadev S, Blanchard  K, et al. Identification of genes implicated in methapyrileneinduced hepatotoxicity by comparing differential gene expression in target and nontarget tissue. Environ Health Perspect  2007; 115: 572-578.

[137] Hamadeh HK, Knight BL, Haugen AC, Sieber S, Amin RP,  Bushel PR, et al. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol  Pathol 2002; 30: 470-482.

[138] Waring JF, Ulrich RG, Flint N, Morfitt D, Kalkuhl A, Staedtler  F, et al. Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Environ Health Perspect 2004; 112: 439-448.

[139] Beekman JM, Boess F, Hildebrand H, Kalkuhl A, Suter L.  Gene expression analysis of the hepatotoxicant methapyrilenein primary rat hepatocytes: an interlaboratory study. Environ  Health Perspect 2006; 114: 92-99.

[140] Uehara T, Kiyosawa N, Hirode M, Omura K, Shimizu T, Ono  A, et al. Gene expression profiling of methapyrilene-induced  hepatotoxicity in rat. J Toxicol Sci 2008; 33: 37-50.

[141] Craig A, Sidaway J, Holmes E, Orton T, Jackson D, Rowlinson R, et al. Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced  hepatotoxicity in the rat. J Proteome Res 2006; 5: 1586-1601.

[142] Mally A, Chipman JK. Non-genotoxic carcinogens: early  effects on gap junctions, cell proliferation and apoptosis in the  rat. Toxicology 2002; 180: 233-248.

[143] Moennikes O, Stahl S, Bannasch P, Buchmann A, Schwarz M.  WY-14, 643-mediated promotion of hepatocarcinogenesis in  connexin32-wild-type and connexin32-null mice. Carcinogenesis 2003; 24: 1561-1565.

[144] Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M,  Willecke K. High incidence of spontaneous and chemically  induced liver tumors in mice deficient for connexin32. Curr  Biol 1997; 7: 713-716.

[145] King TJ, Lampe PD. Mice deficient for the gap junction  protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein  kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004; 25: 669-680

[146] King TJ, Gurley KE, Prunty J, Shin JL, Kemp CJ, Lampe PD.  Deficiency in the gap junction protein connexin32 alters  p27Kip1 tumor suppression and MAPK activation in a tissuespecific manner. Oncogene 2005; 24: 1718-1726.

[147] Hokaiwado N, Asamoto M, Ogawa K, Shirai T. Transgenic  disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.  Toxicol Pathol 2005; 33: 695-701.

[148] Hokaiwado N, Asamoto M, Futakuchi M, Ogawa K, Takahashi  S, Shirai T. Both early and late stages of hepatocarcinogenesis  are enhanced in Cx32 dominant negative mutant transgenic  rats with disrupted gap junctional intercellular communication.  J Membr Biol 2007; 218: 101-106.

[149] Gotow T, Shiozaki M, Higashi T, Yoshimura K, Shibata M,  Kominami E, et al. Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat. Histochem Cell Biol 2008; 130: 583-594.

[150] D'hondt C, Iyyathurai J, Himpens B, Leybaert L, Bultynck G.  Cx43-hemichannel function and regulation in physiology and  pathophysiology: insights from the bovine corneal endothelial  cell system and beyond. Front Physiol 2014; 5: 348.

[151] Maes M, Yanguas SC, Willebrords J, Cogliati B, Vinken M. Connexin and pannexin signaling in gastrointestinal and liver  disease. Transl Res 2015; 166: 332-343.

[152] Dahl G, Keane RW. Pannexin: From discovery to bedside in  11 +/- 4 years? Brain Res 2012; 1487: 150-159.

[153] Penuela S, Harland L, Simek J, Laird DW. Pannexin channels  and their links to human disease. Biochem J 2014; 461: 371- 381.

[154] Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H.  Pannexins, a family of gap junction proteins expressed in brain.  Proc Natl Acad Sci U S A 2003; 100: 13644-13649.

[155] Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G.  Fatty acid and endotoxin activate inflammasomes in mouse  hepatocytes that release danger signals to stimulate immune  cells. Hepatology 2011; 54: 133-144.

[156] Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide  induces and activates the Nalp3 inflammasome in the liver.  World J Gastroenterol 2011; 17: 4772-4778.

[157] Kim HY, Kim SJ, Lee SM. Activation of NLRP3 and AIM2  inflammasomes in Kupffer cells in hepatic ischemia/reperfusion. FEBS J 2015; 282: 259-270.

[158] Xiao F, Waldrop SL, Khimji AK, Kilic G. Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells. Am J Physiol  Cell Physiol 2012; 303: C1034-1044.

[159] Sáez PJ, Shoji KF, Aguirre A, Sáez JC. Regulation of hemichannels and gap junction channels by cytokines in antigenpresenting cells. Mediators Inflamm 2014; 2014: 742734.

[160] Ruch RJ, Klaunig JE. Effects of tumor promoters, genotoxic  carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication. Cell Biol Toxicol 1986; 2: 469- 483.

[161] Budunova IV, Williams GM. Cell culture assays for chemicals  with tumor-promoting or tumor-inhibiting activity based on  the modulation of intercellular communication. Cell Biol  Toxicol 1994; 10: 71-116.

[162] Mesnil M, Krutovskikh V, Omori Y, Yamasaki H. Role of  blocked gap junctional intercellular communication in nongenotoxic carcinogenesis. Toxicol Lett 1995; 82-83: 701-706.

[163] Combes RD. The use of structure-activity relationships and  markers of cell toxicity to detect non-genotoxic carcinogens.  Toxicol In Vitro 2000; 14: 387-399.

[164] Kuraoka A, Iida H, Hatae T, Shibata Y, Itoh M, Kurita T.  Localization of gap junction proteins, connexins 32 and 26, in  rat and guinea pig liver as revealed by quick-freeze, deep-etch  immunoelectron microscopy. J Histochem Cytochem 1993; 41: 971-980.

[165] Nicholson B, Dermietzel R, Teplow D, Traub O, Willecke K,  Revel JP. Two homologous protein components of hepatic gap  junctions. Nature 1987; 329: 732-734.

[166] Zhang JT, Nicholson BJ. Sequence and tissue distribution of a  second protein of hepatic gap junctions, Cx26, as deduced  from its cDNA. J Cell Biol 1989; 109: 3391-3401.

[167] Fowler SL, Akins M, Zhou H, Figeys D, Bennett SA. The liver  connexin32 interactome is a novel plasma membrane-mitochondrial signaling nexus. J Proteome Res 2013; 12: 2597- 2610.

[168] Balasubramaniyan V, Dhar DK, Warner AE, Vivien Li WY,  Amiri AF, Bright B, et al. Importance of Connexin-43 based  gap junction in cirrhosis and acute-on-chronic liver failure. J  Hepatol 2013; 58: 1194-1200.